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Unlike Shiga toxin 2 (stx2) genes, most nucleotide sequences of Shiga toxin 1 (stx1) genes from Shiga
toxin-producing Escherichia coli (STEC), Shigella dysenteriae, and several bacteriophages (H19B, 933J, and
H30) are highly conserved. Consequently, there has been little incentive to investigate variants of stx1 among
STEC isolates derived from human or animal sources. However stx1OX3, originally identified in an OX3:H8
isolate from a healthy sheep in Germany, differs from other stx1 subtypes by 43 nucleotides, resulting in
changes to 12 amino acid residues, and has been renamed stx1c. In this study we describe the development of
a PCR-restriction fragment length polymorphism (RFLP) assay that distinguishes stx1c from other stx1
subtypes. The PCR-RFLP assay was used to study 378 stx1-containing STEC isolates. Of these, 207 were
isolated from sheep, 104 from cattle, 45 from humans, 11 from meat, 5 from swine, 5 from unknown sources,
and 1 from a cattle water trough. Three hundred fifty-five of the 378 isolates (93.9%) also possessed at least
one other associated virulence gene (ehxA, eaeA, and/or stx2); the combination stx1, stx2, and ehxA was the most
common (175 of 355 [49.3%]), and 90 of 355 (25.4%) isolates possessed eaeA. One hundred thirty-six of 207
(65.7%) ovine isolates possessed stx1c alone and belonged to 41 serotypes. Seventy-one of 136 (52.2%) comprised
the common ovine serotypes O5:H, O128:H2, and O123:H. Fifty-two of 207 isolates (25.1%) possessed an stx1
subtype; 27 (51.9%) of these belonged to serotype O91:H. Nineteen of 207 isolates (9.2%) contained both stx1c
and stx1 subtypes, and 14 belonged to serotype O75:H8. In marked contrast, 97 of 104 (93.3%) bovine isolates
comprising 44 serotypes possessed an stx1 subtype, 6 isolates possessed stx1c, and the remaining isolate
possessed both stx1c and stx1 subtypes. Ten of 11 (91%) isolates cultured from meat in New Zealand possessed
stx1c (serotypes O5:H
, O75:H8/H40, O81:H26, O88:H25, O104:H/H7, O123:H/H10, and O128:H2); most of
these serotypes are commonly recovered from the feces of healthy sheep. Serotypes containing stx1 recovered
from cattle rarely were the same as those isolated from sheep. Although an stx1c subtype was never associated
with the typical enterohemorrhagic E. coli serogroups O26, O103, O111, O113, and O157, 13 human isolates
possessed stx1c. Of these, six isolates with serotype O128:H2 (from patients with diarrhea), four O5:H
 isolates
(from patients with hemolytic-uremic syndrome), and three isolates with serotypes O123:H (diarrhea),
OX3:H8 (hemolytic-uremic syndrome), and O81:H6 (unknown health status) represent serotypes that are
commonly isolated from sheep.
Ruminants represent one of the largest reservoirs of Shiga
toxin-producing Escherichia coli (STEC), which is commonly
excreted in the feces of meat-producing animals (3, 5, 6, 14, 22,
27, 29, 30, 50). More than 200 different serotypes of STEC
have been described so far (13, 22, 28, 61), and more than 150
of these have been reported to have been recovered from
humans with hemorrhagic colitis or hemolytic-uremic syn-
drome (HUS) (http://www.microbionet.com.au). However, a
subset of STEC strains (e.g., those of serogroups O26, O103,
O111, O113, and O157), often referred to as enterohemor-
rhagic E. coli (EHEC), are more commonly associated with
such serious afflictions and often possess associated virulence
factors such as plasmid-encoded enterohemolysin and proteins
(EaeA, Tir, and Esp) encoded by the locus of enterocyte ef-
facement (LEE) (10, 22, 47). Although genes such as saa (45),
iha (55), ureC (23, 36), and efaI (39) have been found in
association with the genomes of such STEC strains, further
studies are needed to determine their role in pathogenesis.
Furthermore, differences in levels of secreted LEE proteins
among STEC serotypes may also affect virulence (32).
In marked contrast to the expression of stx2, expression of
stx1 in E. coli is regulated by host-derived signals such as the
availability of iron and body temperature (11). stx1 sequences
derived from STEC O111:H and O48:H21 strains and from
three bacteriophages (H19B, 933J, and H30) have been re-
ported to be very similar to the sequence derived from Shigella
dysenteriae (43) and result in a limited number of amino acid
substitutions. Unlike these common stx1 subtypes, stx1OX3 pos-
sesses 43 nucleotide mismatches compared to stx1933-J, result-
ing in 12 amino acid changes (43). Koch et al. (30) have
examined the presence of stx1OX3 among 148 stx1-containing E.
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coli isolates derived from human and animal sources. The
stx1OX3 gene was shown to be present in 38 of 48 (79.2%)
sheep-derived STEC isolates belonging to serotypes O5:NM,
O125:H, O128:H2, O146:H21, and OX3:H8 but was not
present in isolates with serotype O91:NM. These serotypes are
commonly recovered from ovine but rarely from bovine
sources (5–7, 14, 27, 31, 50). Koch et al., (30) also showed that
stx1OX3-positive strains were recovered from humans with di-
arrhea and that a proportion of these isolates possessed sero-
types commonly associated with STEC from ovine sources.
These preliminary observations suggest that the association of
the stx1OX3 gene with ovine STEC strains from other geograph-
ical locations requires further investigation.
Zhang et al. (63) investigated the presence of the atypical
stx1OX3 variant among 212 STEC strains recovered from hu-
mans. These authors renamed stxOX3, designating it stx1c (63).
Since stx1c has now been identified among serologically diverse
STEC strains (30, 58, 63), we retained this nomenclature for
our study. Zhang et al. (63) reported stx1c in 36 STEC strains,
of which 23 concomitantly possessed stx2d, 12 possessed stx1c
alone, and 1 possessed both stx1c and stx2. Of the 36 stx1c-
positive strains, 19 were recovered from asymptomatic patients
and 16 were derived from fecal samples of patients with un-
complicated diarrhea. Only a single stx1c-positive isolate was
recovered from a patient with HUS. The 36 stx1c-positive iso-
lates belonged to 15 serotypes, none of which included the
major STEC serogroups (O26, O103, O111, O113, O145, and
O157) (63). Several studies (19, 30, 50, 58, 63) suggest that
sheep may be a natural reservoir of stx1c-positive STEC strains
that enter the human food chain.
Shiga toxin genes (stx) are encoded in the genomes of lamb-
doid phages (51). Bacteriophage transmission represents the
major vehicle in the spread of stx among serologically diverse
populations of E. coli (30, 51) and contributes significantly to
the emergence of new STEC clones (51). The location of stx
downstream of phage lysis genes suggests that phage promot-
ers (57, 59) control the expression of Shiga toxin. Bacterio-
phages survive better in water than their bacterial hosts and are
reported to be more resistant to chlorination and pasteuriza-
tion (34, 35). Monitoring stx subtypes within ruminant and
environmental populations of STEC should lead to a better
understanding of the movement of bacteriophage within these
environments.
Shiga toxins play a major role in inducing vascular injury in
the intestinal microcirculation and have been shown to directly
affect the intestinal epithelium, although different responses
have been reported for different hosts (reviewed in reference
40). More specifically, Shiga toxins perturb cytokine expression
patterns as a consequence of their interaction with epithelial
cells (1, 56, 62). Rabbit models have been used to demonstrate
the ability of stx1-positive strains to induce more-severe diar-
rhea and mucosal injury (54), increased inflammatory changes,
and elevated mucosal interleukin-1 activity (8) compared with
those in rabbits infected with isogenic strains lacking stx1. The
ability of purified stx1 to induce similar inflammatory responses
when inoculated intragastrically into rabbits reinforces these
observations (41). However, to our knowledge, the abilities of
different Shiga toxin 1 subtypes to induce these physiological
changes have not been addressed.
A recent report demonstrating that bovine crypt intestinal
epithelium, lining the ileum and jejunum of the small intestine
and the cecum and colon of the large intestine, expresses Gb3
receptors for verotoxin 1 (stx1) from E. coli O157:H7 has po-
tentially profound implications for the role of Shiga toxin in
the colonization of ruminant species by STEC (25). The hy-
pothesis that Shiga toxin 1 may modulate the bovine immune
response is supported by observations that this toxin (i) has
been shown to inhibit the activation and proliferation of sub-
populations of bovine lymphocytes (33), (ii) suppresses bovine
leukemia virus-related spontaneous lymphocyte proliferation
(18), and (iii) binds to submucosal lymphoid aggregates (25).
Although STEC typically inhabits the gastrointestinal tracts of
healthy meat-producing animals, certain subpopulations of
STEC may also induce gastrointestinal disease in these animals
(9, 60). Wieler et al. (60) showed that the majority of STEC
isolates recovered from diarrheic calves concomitantly pos-
sessed eaeA and stx1, and they concluded that stx1-positive
strains are more virulent for calves. To our knowledge, the
presence of different stx1 subtypes among STEC isolates de-
rived from cattle has not been intensively investigated.
Previously, we and others have shown that STEC strains that
commonly inhabit the gastrointestinal tracts of healthy sheep
and cattle represent serologically distinct populations (5–7, 14,
27, 58). Furthermore, it has also been demonstrated that STEC
isolates with stx2 that are commonly recovered from sheep
predominantly possess the stx2d subtype (46, 48, 50) whereas
bovine stx2-containing STEC isolates typically possess stx2 and
stx2vha/b subtypes (3; our unpublished data). We considered it
important to subtype stx1 genes in a serologically diverse col-
lection of STEC isolates derived predominantly from rumi-
nants in Australia in order to determine if different stx1 sub-
types also associate with particular hosts. In this study a PCR-
restriction fragment length polymorphism (RFLP) assay which
differentiates stx1c from the common stx1-related sequences
was developed. The assay was used to characterize 378 stx1-
containing STEC isolates derived predominantly from ovine
and bovine sources. We also examined stx1 subtypes in 45
human STEC strains derived mostly from patients with gastro-
intestinal and systemic diseases.
MATERIALS AND METHODS
STEC isolates. Three hundred seventy-eight stx1-containing STEC isolates
were used in this study (Table 1); of these, 313 were derived from healthy
meat-producing animals, 45 were of human origin, 11 were from a blind study of
meat from New Zealand, 5 had unknown histories, 3 were individual isolates
from bovines of unknown health status, and 1 was from a water source. Two
hundred seven isolates were derived from ovine sources (203 animals) and were
obtained from the Elizabeth Macarthur Agricultural Institute (EMAI), Camden,
New South Wales, Australia. One hundred four isolates were of bovine origin (83
animals); of these, 99 were obtained from the EMAI and 5 were from the
Microbiological Diagnostic Unit (MDU), Melbourne, Australia. The majority of
these STEC isolates were collected from healthy sheep and cattle in eastern
Australia (14, 27; our unpublished data). Five stx1-containing isolates from
healthy pigs from the EMAI collection were also included. Thirty-seven stx1-
containing human isolates were from the MDU, and eight isolates were from the
National Reference Laboratory for Foodborne Diseases, Bern, Switzerland. The
37 human isolates from the MDU included 4 isolates (O81:H6, OR:H, Ont:H,
and O26:H11) from New Zealand (from individuals of unknown health status),
3 O157:H7 isolates from the 1996 outbreak in Japan (kindly supplied by H.
Watanabe), 2 O111:H isolates from Italy (kindly provided by A. Caprioli), and
a single O157:H7 isolate from the Jack-in-the-Box outbreak in the United States
(Table 1). B. Bochner kindly supplied isolates from the United States. These
isolates were cultured by previously published procedures (14).
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TABLE 1. Virulence factor profiles and stx1 subtypes among STEC isolates of animal and human origins
Sourcea Clinicalconditionb Serotype
No. of
isolates
No. of animals
or humans
Virulence factor profile No. of isolates with stx1subtype:
stx1 stx2 eaeA ehxA stx1 stx1c stx1/stx1c
Ovine Healthy O2:H29 1 1     1
Bovine Healthy O3:H7 7 2     7
Bovine Healthy O5:H 3 3     1 2
Bovine Diagnostic O5:H 5 1     5
Ovine Healthy O5:H 14 14     14
Ovine Healthy O5:H 7 6     7
Ovine Healthy O5:H 1 1     1
Human/MDU HUS O5:H 1 1     1
Human/MDU HUS O5:H 2 2     2
Human/MDU HUS O5:H 1 1     1
Meat/New Zealand Unknown O5:H 1 1     1
Bovine Healthy O5:H7 3 3     3
Ovine Healthy O5:HR 1 1     1
Ovine Healthy O6:H 1 1     1
Ovine Healthy O6:H 1 1     1
Ovine Healthy O8:Hnt 1 1     1
Human/NRLFD HUS O8:H8 1 1     1
Bovine Healthy O8:H16 1 1     1
Ovine Healthy O21:H21 1 1     1
Bovine Healthy O26:H 1 1     1
Ovine Healthy O26:H 2 2     2
Human/MDU Diarrhea O26:H 3 3     3
Unknown/United States Unknown O26:H 1 1     1
Bovine Healthy O26:H11 11 7     11
Bovine Healthy O26:H11 1 1     1
Bovine Healthy O26:H11 1 1     1
Ovine Healthy O26:H11 4 4     4
Human/MDU Diarrhea O26:H11 3 3     3
Human/MDU Diarrhea O26:H11 6 5     6
Human/NRLFD Diarrhea O26:H11 2 2     2
Human/New Zealand Unknown O26:H11 1 1     1
Bovine Healthy O28:H 1 1     1
Bovine Healthy O32/83:H7 1 1     1
Bovine Healthy O37:H10 1 1     1
Ovine Healthy O55:H20 1 1     1
Bovine Healthy O68:H 1 1     1
Ovine Healthy O69:H8 1 1     1
Ovine Healthy O75:H 1 1     1
Bovine Healthy O75:H1 1 1     1
Ovine Healthy O75:H8 3 3     1 1 1
Ovine Healthy O75:H8 1 1     1
Ovine Healthy O75:H8 16 16     1 2 13
Ovine Healthy O75:H8 1 1     1
Meat/New Zealand Unknown O75:H8 1 1     1
Ovine Healthy O75:H40 1 1     1
Ovine Healthy O75:H40 1 1     1
Meat/New Zealand Unknown O75:H40 1 1     1
Ovine Healthy O77:H4 1 1     1
Ovine Healthy O77:H 1 1     1
Human/New Zealand Unknown O81:H6 1 1     1
Ovine Healthy O81:H26 1 1     1
Meat/New Zealand Unknown O81:H26 1 1     1
Bovine Healthy O81:H31 1 1     1
Bovine Healthy O82:H40 2 2     2
Bovine Healthy O82:H8 6 6     6
Continued
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TABLE 1—Continued
Sourcea Clinicalconditionb Serotype
No. of
isolates
No. of animals
or humans
Virulence factor profile No. of isolates with stx1subtype:
stx1 stx2 eaeA ehxA stx1 stx1c stx1/stx1c
Bovine Healthy O84:H 1 1     1
Ovine Healthy O84:H 1 1     1
Bovine Healthy O84:H2 1 1     1
Ovine Healthy O88:H8 1 1     1
Meat/New Zealand Unknown O88:H25 1 1     1
Ovine Healthy O91:H 21 20     18 3
Ovine Healthy O91:H 6 6     4 2
Ovine Healthy O91:H 5 5     5
Human/MDU Healthy O91:H 2 2     2
Meat/New Zealand Unknown O91:H 1 1     1
Bovine/Hong Kong Unknown O91:H14 1 1     1
Ovine Diagnostic O103:H2 1 1     1
Human/MDU Diarrhea O103:H2 1 1     1
Ovine Healthy O103:H38 1 1     1
Meat/New Zealand Unknown O104:H7 1 1     1
Meat/New Zealand Unknown O104:H 1 1     1
Ovine Healthy O106:H18 1 1     1
Ovine Healthy O106:HR 1 1     1
Bovine Healthy O108:H7 3 3     3
Bovine Healthy O108:H7 1 1     1
Bovine Healthy O110:H40 1 1     1
Bovine Healthy O111:H 2 2     2
Human/Italy Unknown O111:H 1 1     1
Human/Italy Unknown O111:H 1 1     1
Unknown/Canada Unknown O111:H 1 1     1
Unknown/United States Unknown O111:H 1 1     1
Unknown/Germany Unknown O111:H 1 1     1
Bovine Healthy O111:H8 2 1     2
Ovine Healthy O112ab:H2 2 2     2
Ovine Healthy O112ab:H2 1 1     1
Ovine Healthy O112ab:H2 1 1     1
Bovine Healthy O113:H4 1 1     1
Bovine/Canada Unknown O113:H4 1 1     1
Bovine Unknown O113:H21 1 1     1
Bovine Unknown O113:H21 1 1     1
Human/NRLFD Diarrhea O117:H7 2 2     2
Bovine Healthy O117:H21 1 1     1
Human/NRLFD Diarrhea O118:H16 1 1     1
Ovine Healthy O121:H2 1 1     1
Ovine Healthy O123:H 1 1     1
Ovine Healthy O123:H 1 1     1
Ovine Healthy O123:H 19 19     19
Human/NRLFD Diarrhea O123:H 1 1     1
Meat/New Zealand Unknown O123:H 1 1     1
Meat/New Zealand Unknown O123:H10 1 1     1
Ovine Healthy O123:H11 1 1     1
Ovine Healthy O128:H2 19 19     19
Ovine Healthy O128:H2 5 5     5
Ovine Healthy O128:H2 2 2     2
Ovine Healthy O128:H2 1 1     1
Human/MDU Diarrhea O128:H2 4 4     4
Human/MDU Diarrhea O128:H2 2 2     2
Meat/New Zealand Unknown O128:H2 1 1     1
Ovine Healthy O128:H-/H2 1 1     1
Ovine Healthy O128:H8/H2 1 1     1
Continued
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TABLE 1—Continued
Sourcea Clinicalconditionb Serotype
No. of
isolates
No. of animals
or humans
Virulence factor profile No. of isolates with stx1subtype:
stx1 stx2 eaeA ehxA stx1 stx1c stx1/stx1c
Ovine Healthy O128:Hnt 1 1     1
Bovine Healthy O130:H11 2 2     2
Bovine Healthy O130:H11 1 1     1
Bovine Healthy O130:H38 2 2     2
Bovine Healthy O149:H19 1 1     1
Ovine Healthy O152:H21 1 1     1
Ovine Healthy O153:H 1 1     1
Bovine Healthy O153:H8 1 1     1
Ovine Healthy O153:H8 1 1     1
Bovine Healthy O153:H21 1 1     1
Ovine Healthy O153:H25 3 3     3
Ovine Healthy O153:H25 1 1     1
Ovine Healthy O153:H25 1 1     1
Bovine Healthy O153:HR 1 1     1
Water N/A O154:H 1 1     1
Ovine Healthy O154:HR 1 1     1
Bovine Healthy O157:H 1 1     1
Ovine Healthy O157:H 2 2     2
Ovine Healthy O157:H 2 2     2
Porcine Healthy O157:H 5 2     5
Bovine Healthy O157:H7 1 1     1
Bovine/Finland Unknown O157:H7 1 1     1
Human/Japan Unknown O157:H7 1 1     1
Human/Japan Unknown O157:H7 1 1     1
Human/United States Unknown O157:H7 1 1     1
Unknown/United States Unknown O157:H7 1 1     1
Ovine Healthy O157:H21 1 1     1
Ovine Healthy O158:HR 1 1     1
Bovine Healthy O163:H 1 1     1
Bovine Healthy O163:H19 1 1     1
Ovine Healthy O163:H19 1 1     1
Ovine Healthy O168:H21 1 1     1
Bovine Healthy Ont:H1 2 2     2
Bovine Healthy Ont:H2 2 1     2
Bovine Healthy Ont:H4 1 1     1
Bovine Healthy Ont:H8 1 1     1
Ovine Healthy Ont:H8 1 1     1
Ovine Healthy Ont(A):H8 1 1     1
Bovine Healthy Ont:H10 1 1     1
Bovine Healthy Ont:H11 6 2     6
Bovine Healthy Ont:H16 2 1     2
Bovine Healthy Ont:H19 1 1     1
Ovine Healthy Ont:H19 1 1     1
Bovine Healthy Ont:H21 2 2     2
Bovine Healthy Ont:H30 1 1     1
Bovine Healthy Ont:H41 1 1     1
Ovine Healthy Ont:H49 1 1     1
Bovine Healthy Ont:H 2 1     2
Bovine Healthy Ont:H 1 1     1
Ovine Healthy Ont:H 1 1     1
Ovine Healthy Ont:H 2 2     2
Human/MDU Unknown Ont:H 1 1     1
Human/New Zealand Unknown Ont:H 1 1     1
Ovine Healthy Ont(A):H 1 1     1
Ovine Healthy Ont:HR 9 7     9
Continued
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Multiplex PCR analysis of STEC isolates. All isolates were prepared and
subjected to multiplex PCR for detection of STEC virulence factors stx1, stx2,
ehxA, and eaeA as described previously (44) with the following modification: for
DNA preparation, an Instagene matrix (Bio-Rad, Richmond, Calif.) was used as
described previously (17). Amplified PCR products were then resolved by aga-
rose gel electrophoresis (2%, wt/vol) and stained with ethidium bromide (5
g/ml). Visualization was achieved by UV illumination, and images were cap-
tured by using a GelDoc 1000 image analysis station.
stx1 subtyping. The Clustal W program was used to align stx1 genes deposited
in GenBank, and the Mapplot program, accessed via the Australian National
Genomic Information Service (ANGIS) (www.angis.org.au), was used to identify
restriction enzyme cleavage sites. Since all Shiga toxin 1 gene sequence variants
with the exception of stx1c display more than 99% sequence identity with stx1933J,
all non-stx1c sequences will be referred to as stx1 subtypes in this report. To
subtype stx1 sequences, a 603-bp fragment of the gene was amplified by using the
Gannon F and R primers (Table 2). Restriction enzymes CfoI and RsaI were
used to cut the 603-bp fragment because they were predicted to generate RFLP
profiles that readily distinguish stx1c from other stx1 subtypes. PCR assays were
carried out in a 50-l total volume containing 5 l of a whole-cell DNA template
prepared by using an Instagene matrix (17), 10 mM Tris-HCl (pH 8.3), 10 mM
KCl, 2 mM MgCl2, 10 pmol of each primer, 200 M each deoxynucleoside
triphosphate, and 1 U of Taq DNA. Thermocycler steps included an initial
denaturation step of 94°C for 180 s, followed by 35 cycles of denaturation (94°C
for 60 s), annealing (60°C for 60 s), and extension (72°C for 120 s). A final
extension step of 72°C for 300 s completed the PCR. The PCR product (3 to 5
g) was separately digested with 5 U each of CfoI and RsaI in 1 buffer L
(Roche Pharmaceuticals) and was incubated at 37°C for a minimum of 4 h.
Agarose gel (2%) electrophoresis was used to separate the restricted fragments,
and subtypes were identified according to their restriction patterns.
Sequence analysis of stx1. The stx1 genes from two isolates of serotypes O26:
H11 (isolate 507) and O5:H (isolate 904) were sequenced. These isolates were
selected because O26:H11 and O5:H are common serotypes of STEC isolates
recovered from healthy adult cattle and sheep, respectively. Secondly, serotype
O26:H11 possesses an stx1 RFLP profile that is indistinguishable from those of
other stx1 subtypes, and serotype O5:H possesses an stx1 RFLP profile that is
indistinguishable from that of stx1c. A 1,470-bp fragment encoding both A and
TABLE 1—Continued
Sourcea Clinicalconditionb Serotype
No. of
isolates
No. of animals
or humans
Virulence factor profile No. of isolates with stx1subtype:
stx1 stx2 eaeA ehxA stx1 stx1c stx1/stx1c
Ovine Healthy Ont:Hnt 1 1     1
Human/MDU Healthy Ont:Hnt 1 1     1
Ovine Healthy OR:H2 2 2     2
Ovine Healthy OR:H2 1 1     1
Ovine Healthy OR:H4 2 2     2
Human/Japan Unknown OR:H7 1 1     1
Bovine Healthy OR:H31 1 1     1
Ovine Healthy OR:HR 1 1     1
Bovine Healthy OR:H 1 1     1
Ovine Healthy OR:H 2 2     2
Ovine Healthy OR:H 1 1     1
Human/New Zealand Unknown OR:H 1 1     1
Ovine Healthy OX3:H2 1 1     1
Bovine Healthy OX3:H8 1 1     1
Ovine Healthy OX3:H8 1 1     1
Human/NRLFD HUS OX3:H8 1 1     1
Ovine Healthy OX3:HR 3 3     3
a NRLFD, National Reference Laboratory for Foodborne Diseases.
b N/A, not applicable.
TABLE 2. Primers used to amplify and sequence stx1
Primer name Primer sequence Size (bp) Reference
stx1 typing
Gannon F 5-ACACTGGATGATCTCAGTGG-3 603 21
Gannon R 5-CTGAATCCCCCTCCATTATG-3
stx1 sequencing
Paton 1F 5-TCGCA-TGAGATCTGACC-3 1,470 43
Paton 1 R 5-AACTGACTGAATTGAGATG-3
Paton 2 F 5-ATAAATCGCCATTCGTTGACTAC-3 180 44
Paton 2 R 5-AGAACGCCCACTGAGATCATC-3
Gannon F 5-ACACTGGATGATCTCAGTGG-3 603 21
Gannon R 5-CTGAATCCCCCTCCATTATG-3
Paton 1 F 5-TCGCATGAGATCTGACC-3 448 This study
Vidiya 1 R 5-AATAAGCCGTAGATTATT-3
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B subunits of all Shiga toxin 1 genes was amplified by using primers Paton 1F and
Paton 1R (Table 2) in a reaction volume of 50 l. PCR was carried out by using
5 l of a whole-cell DNA template prepared by using an Instagene matrix (17),
10 mM Tris-HCl (pH 8.3), 10 mM KCl, 2 mM MgCl2, 10 pmol of each primer,
200 M each deoxynucleoside triphosphate, and 1 U of Taq DNA polymerase.
Thermocycler steps involved an initial denaturation step of 94°C for 180 s,
followed by 35 cycles of denaturation (94°C for 30 s), annealing (54°C for 30 s),
and extension (72°C for 60 s). A final extension step of 72°C for 300 s completed
the PCR. The amplified PCR product was separated by agarose gel electrophore-
sis (2%) and purified for DNA sequencing by using the QIAquick DNA purifi-
cation kit (Qiagen, Hilden, Germany). Primers used for sequencing are listed in
Table 2. Sequencing reactions were performed by using the Big Dye terminator
cycle sequencing ready reaction DNA sequencing kit and electrophoresed on an
ABI Prism 377 DNA sequencer (Perkin-Elmer, Santa Clara, Calif.) as described
previously (50). Auto Assembler software (Perkin-Elmer) was used to compile
and analyze the DNA sequences. Nucleotide and amino acid analyses were
performed by using programs accessed via ANGIS. Sequences were compared
with those deposited in public databases by using the BlastN and Blast P algo-
rithms (2).
RESULTS
Detection of STEC virulence factors by multiplex PCR. Of
378 stx1-containing isolates, 207, 104, and 45 were derived from
ovine, bovine, and human sources, respectively. Eleven isolates
from New Zealand meat, five serotype O157:H isolates re-
covered from porcine feces, five isolates from unknown
sources, and a single isolate cultured from a water trough
completed the collection. Among the 207 ovine isolates, the
predominant virulence factor combinations were represented
by 108 isolates (52.2%) with stx1, stx2, and ehxA; 46 isolates
(22.2%) with stx1 and ehxA; 22 isolates (10.6%) with stx1 and
stx2; 11 isolates (5.3%) with stx1 alone; 9 isolates (4.3%) with
stx1, eaeA, and ehxA; and 7 isolates (3.4%) with all four factors.
Of 104 bovine isolates, 54 (52.0%) contained stx1, stx2, and
ehxA; 24 (23.1%) contained stx1, ehxA, and eaeA; 6 (5.8%)
contained stx1 only; 6 (5.8%) possessed stx1 and ehxA; 7 (6.7%)
contained all four factors; 6 (5.8%) possessed stx1 and stx2; and
1 (0.96%) possessed stx1, stx2, and eaeA. Of 45 human isolates,
20 (44.4%) contained stx1, ehxA, and eaeA; 6 (13.3%) con-
tained stx1, stx2, and ehxA; 5 (11.1%) contained stx1 and stx2; 4
(8.9%) contained stx1 and eaeA; 3 (6.7%) contained stx1 alone;
4 (8.9%) contained stx1 and ehxA; 2 (4.4%) contained all four
factors; and 1 (2.2%) contained stx1, stx2, and ehxA. Of the 11
meat isolates, 7 (63.6%) contained stx1, stx2, and ehxA; 3
(27.3%) contained stx1 alone; and 1 (9.1%) contained stx1 and
ehxA. All five porcine O157:H isolates included in this study
were positive for stx1, eaeA, and ehxA. STEC serotypes and
their virulence factor profiles are listed in Table 1.
Development of a PCR-RFLP assay to identify stx1c. RFLP
patterns generated by separate digestions of a 603-bp fragment
of stx1 with CfoI and RsaI are shown in Fig. 1A and B, respec-
tively. The 603-bp fragment amplified from STEC isolates pos-
sessing stx1 subtypes (defined as stx1 subtypes that share more
than 99% nucleotide sequence identity with stx1933J) generated
fragments of 322, 135, 83, and 63 bp with CfoI and 603 bp with
RsaI (Fig. 1, lanes 1 to 5 and 7). However, the 603-bp fragment
amplified from STEC isolates possessing stx1c generated frag-
ments of 414 and 189 bp with CfoI and 386 and 217 bp with
RsaI, respectively (Fig. 1, lanes 6 and 8 to 11). This assay was
used to type stx1 from 378 stx1-containing STEC isolates (Table
1).
stx1 subtyping and association with serotype. Of 207 ovine
isolates, 136 (65.7%) possessed stx1c, 52 (25.1%) possessed an
stx1 subtype, and 19 (9.2%) concomitantly possessed both stx1c
and stx1 subtypes. Interestingly, STEC isolates that possessed
both stx1c and stx1 were all (except one isolate) of ovine origin
and belonged either to serotype O75:H8 (accounting for 14 of
the 21 ovine isolates with this serotype) or to one of the
following serotypes (each represented by a single isolate):
O103:H38, Ont:H8, O88:H8, O55:H20, and O5:HR. A single
bovine isolate (serotype O37:H10) possessed both stx1c and a
common stx1 subtype (Table 1).
Ovine STEC isolates positive for stx1c alone comprised 41
serotypes, of which the most common were O128:H2 (with all
28 isolates of this serotype positive for stx1c alone), O5:H
 (all
22 isolates), O123:H (all 21 isolates), Ont:HR (all 9 isolates),
O153:H25 (all 5 isolates), O91:H (5 of 32 isolates), O75:H8
(4 of 21 isolates), and OX3:HR (all 3 isolates). With the ex-
ception of isolates with serotypes OR:H/H2/H4, O6:H, and
O75:H40, the remaining 28 serotypes containing stx1c were
represented by a single isolate (Table 1).
Ovine isolates that possessed stx1 alone belonged to sero-
types O26:H (with both ovine isolates of this serotype pos-
sessing stx1 alone), O26:H11 (all 4 isolates), O91:H
 (27 of 32
isolates), O157:H (4 of 4 isolates), O75:H8 (3 of 21 isolates),
O112ab:H2 (3 of 4 isolates), and Ont:H (2 of 3 isolates); each
of the remaining serotypes was represented by a single isolate
(Table 1). Serogroup O26 strains are not commonly isolated
from ovine feces (14). Six isolates belonging to serogroup O26
included in this study were recovered from newborn lambs
FIG. 1. CfoI (A) and RsaI (B) digests of PCR products obtained
with primers Gannon F and Gannon R. Lanes: M, 100-bp Plus marker;
1, O82:H8 (bovine feces); 2, O3:H7 (bovine feces); 3, O26:H11 (bovine
feces); 4, OX3:H8 (bovine feces); 5, O130:H11 (bovine feces); 6,
O5:H (ovine feces); 7, O91:H (ovine feces); 8, O123:H (ovine
feces); 9, O75:H8 (ovine feces); 10, O128:H2 (ovine feces); 11,
O123:H (ovine feces).
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during intensive sampling on a property that simultaneously
grazed sheep and cattle, and their stx1 subtypes were indistin-
guishable from stx1 subtypes found in O26 isolates recovered
from cattle.
Of 104 bovine isolates possessing stx1, 97 (93.3%) contained
an stx1 subtype and belonged to 44 serotypes including O26:
H11 (13 of 13 bovine isolates of this serotype), O3:H7 (7 of 7
isolates), O82:H8 (6 of 6 isolates), Ont:H11 (6 of 6 isolates),
O5:H (6 of 8 isolates), O5:H7 (3 of 3 isolates), O108:H7 (4 of
4 isolates), O82:H40 (2 of 2 isolates), O111:H (2 of 2 iso-
lates), O111:H8 (2 of 2 isolates), O113:H4 (2 of 2 isolates),
O113:H21 (2 of 2 isolates), O130:H11 (3 of 3 isolates), O130:
H38 (2 of 2 isolates), and O157:H7 (2 of 2 isolates); the re-
maining serotypes were each represented by a single isolate
(Table 1). Only 6 of 104 (5.8%) bovine isolates contained stx1c.
Those containing stx1c alone belonged to serotypes O5:H

(accounting for two of eight bovine isolates of this serotype),
O153:H8 (one isolate), O117:H21 (one isolate), Ont:H4 (one
isolate), and Ont:H10 (one isolate). A single isolate of serotype
O37:H10 contained both stx1c and stx1 subtypes (Table 1).
Of 45 human isolates, 31 were isolated from patients with
diarrhea (25 isolates, 7 serotypes) or HUS (6 isolates, 3 sero-
types) (Table 1). Two isolates (both serotype O91:H) were
recovered from an asymptomatic patient, and one isolate was
from a healthy individual (serotype Ont:Hnt). Of the remain-
ing 11 human isolates, recovered from patients of unknown
health status, 4 (serotypes O81:H6, O26:H11, Ont:H, and
OR:H) were from New Zealand, 3 (2 with serotype O157:H7
and one with OR:H7) were recovered during a HUS outbreak
in Japan in 1996, 2 (both serotype O111:H) were from Italy,
1 (serotype O157:H7, associated with the Jack-in-the-Box-out-
break) was from the United States, and 1 was from Australia
(serotype Ont:H) (Table 1). All six human isolates with se-
rotype O128:H2 (diarrhea), four O5:H (HUS) isolates, one
isolate with serotype O123:H (diarrhea), and one isolate with
OX3:H8 (HUS)—all serotypes frequently isolated from
sheep—as well as a single isolate of serotype O81:H6 from a
patient in New Zealand possessed stx1c. Twelve isolates with
serotype O26:H11 and 3 with serotype O26:H (14 of these 15
isolates were recovered from patients with diarrhea), both se-
rotypes commonly isolated from bovine feces, possessed an stx1
subtype. Interestingly, two isolates with serotype O91:H (re-
covered from asymptomatic patients), a common ovine sero-
type, possessed an stx1 subtype. Serotype O91:H
 isolates are
frequently recovered from ovine feces and are atypical com-
pared with other common ovine STEC serotypes in that they
possess an stx1 subtype. Isolates of serotypes O111:H
 (two
isolates from patients of unknown health status), O117:H7
(two, from patients with diarrhea), O157:H7 (three; unknown
health status), and Ont:H2 (two; unknown health status), and
one isolate each of serotypes O8:H8 (HUS), O103:H2 (diar-
rhea), O118:H16 (diarrhea), Ont:Hnt (healthy patient),
OR:HR (unknown health status), and OR:H (unknown
health status), all possessed an stx1 subtype. STEC isolates
belonging to the classical EHEC types (serogroups O26, O103,
O111, O113, and O157) did not possess stx1c alone, an obser-
vation that supports the findings of others (30, 63). Of the 11
isolates from New Zealand meat, those with serotypes O5:H,
O75:H8/H40, O81:H26, O88:H25, O104:H/H7, O123:H/
H10, and O128:H2 all possessed stx1c while 1 isolate of sero-
type O91:H possessed an stx1 subtype.
All five O157:H isolates recovered from healthy pigs in-
cluded in this study possessed an stx1 subtype (Table 1).
stx1 subtypes in STEC isolates containing the eaeA gene. Of
90 STEC isolates that contained eaeA, 81 (90%) possessed an
stx1 subtype (Table 1). Of the remaining nine isolates (sero-
types O5:HR, O37:H10, O55:H20, O88:H8, and Ont:H8), five
contained both common stx1 and stx1c subtypes and four (se-
rotypes O5:H, O106:HR, O123:H, and O158:HR) con-
tained the stx1c subtype (Table 1). These data suggest that
STEC isolates containing eaeA predominantly possess an stx1
subtype.
stx1 sequence analysis. stx1 from isolates of serotypes O26:
H11 (isolate 507) and O5:H (isolate 904), which were pre-
dicted by RFLP analyses to possess stx1 and stx1c subtypes,
respectively, and which were representative of the two stx1
RFLP patterns identified in this study, were examined by DNA
sequence analysis. The stx1 sequence derived from serotype
O26:H11 showed a single nucleotide difference (A3T) from
the stx1J933 sequence (GenBank accession no. AF034975.3)
(38) in the A subunit (S673T). The nucleotide sequence de-
rived from serotype O5:H showed 100% homology with the
reported stx1c gene sequence (accession no. Z36901.1) (43).
DISCUSSION
This study describes the development of a PCR-RFLP assay
that differentiates stx1c from other stx1 subtypes and its appli-
cation for subtyping stx1 genes in 378 STEC isolates predom-
inantly from feces of various meat-producing animals and hu-
mans. The most striking result of this study was the
predominance of stx1c (136 of 207 isolates [65.7%]) in STEC
isolated from ovine feces and the infrequent identification of
this subtype in STEC from bovine feces (6 of 104 isolates
[5.8%]). Of the 207 ovine STEC isolates, 70 (33.8%) belonged
to the common ovine serotypes O5:H, O128:H2, and
O123:H (5–7, 14, 30, 50, 58; our unpublished data) and were
positive for the stx1c gene. Isolates with serotype O91:H
,
another commonly reported ovine STEC serotype (14, 30, 58),
predominantly possessed an stx1 subtype (27 of 32 isolates
[84.4%]), although 5 isolates possessed stx1c. In similar studies
of ovine STEC, all 10 O91:H isolates from Germany (30) and
12 O91:H isolates from Norway (58) were reported to possess
an stx1 subtype, suggesting that this serotype is rarely infected
by lysogenic phage carrying stx1c (see below). Urdahl et al. (58)
suggested that STEC isolates belonging to the O91 serogroup
might be less host specific than those of other serotypes, since
they have been isolated from cattle, sheep, pigs, goats, and
humans and are found with different flagellar types including
H, H10, H14, H21, and H49.
In our study, the stx1c gene was identified among a serolog-
ically diverse collection of STEC isolates, the vast majority of
which have been recovered only from ovine feces (14, 27, 30,
58; our unpublished data). In a study of sheep in Germany,
stx1c was detected in 48 stx1-containing STEC isolates compris-
ing serogroups O5, O125, O128, O146, and OX3 (30). A study
in Norway (58) reported stx1c in 73 of 102 (71.6%) stx1-positive
isolates, belonging to 12 different serotypes, from ovine feces;
serotypes O5:NM, O6:H10, O91:NM, and O128:NM predom-
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inated. A lysogenic bacteriophage carrying the stx1c gene has
been isolated from STEC derived from ovine feces, and the
ability of the phage to integrate into the genomes of genetically
heterogeneous E. coli types has been established (30). The
authors suggested that the promiscuous nature of this bacte-
riophage may provide an explanation for the presence of the
stx1c gene among serologically diverse populations of STEC
belonging to different clonal lineages. Our study confirms and
extends these preliminary observations by showing that the
stx1c gene is present among 51 STEC serotypes predominantly
of ovine origin. The low prevalence of this gene in STEC
recovered from bovine sources (6 of 104 isolates [5.8%]) sug-
gests that either phage carrying stx1c are not prevalent in the
gastrointestinal tracts of cattle or most serotypes that inhabit
cattle are refractory to infection by this phage.
Although STEC strains of serotype O5:H are predomi-
nantly isolated from sheep and not cattle (5, 14, 58), they are
occasionally isolated from the latter. Eight serotype O5:H
isolates from cattle were included in this study. Three of these
STEC isolates were recovered from young calves, and two of
these possessed stx1c; the other five O5:H
 isolates were re-
covered from diarrheic cattle and possessed an stx1 subtype.
Hornitzky et al. have recovered only one O5:H STEC isolate
from healthy Australian cattle despite intensive fecal sampling
(27), and this serotype was not reported among STEC isolates
recovered from healthy cattle in studies undertaken in Japan
(29), France (49), and Spain (9). However, serotype O5:H
STEC isolates have previously been recovered from diarrheic
calves in Australia (26), the United States (15), Argentina (42),
and Germany (60) and from healthy cattle in two studies (22,
28). In one of the studies of healthy cattle (22), all 10 bovine
O5:H isolates were shown to simultaneously possess stx1,
eaeA, and ehxA. Furthermore, O5:H isolates recovered from
diarrheic calves in Germany (60), Argentina (42), and Austra-
lia (26) all possessed eaeA. O5:H isolates recovered from
healthy sheep (14, 58; our unpublished data) very rarely pos-
sess eaeA. These data suggest the existence of different clonal
populations of serotype O5:H, and further genetic studies are
in progress to test this hypothesis.
Of 207 ovine stx1-containing STEC isolates, 20 (9.7%) pos-
sessed eaeA. Of these, 13 contained an stx1 subtype, 3 con-
tained stx1c, and the remaining 4 contained both stx1 and stx1c
subtypes. Similarly, 32 of 104 (30.8%) bovine stx1-containing
STEC isolates possessed eaeA and none contained stx1c. Of the
165 isolates in this study that possessed the stx1c gene, 137
(83.0%) were found to contain ehxA. Isolates with STEC se-
rotypes that are commonly recovered from patients with seri-
ous diseases typically carry the eaeA gene and also possess the
EHEC plasmid, which encodes ehxA and other potential viru-
lence-associated factors (10, 22, 61). The majority (82 of 136
[60.3%]) of ovine STEC isolates that possessed stx1c also con-
tained stx2. Previous studies have shown that STEC isolates
recovered from ovine feces typically possess the stx2d subtype
(50, 58), a subtype that is not commonly found in STEC iso-
lated from patients with severe disease (19, 46, 47). A study of
STEC recovered from sheep in Norway reported that 44 of 57
stx2-positive isolates possessed stx2d (58). Collectively, these
data lend weight to the hypothesis that STEC isolates recov-
ered from sheep feces are not commonly associated with HUS.
However, it should be emphasized that we have characterized
five STEC isolates from humans with HUS (four O5:H iso-
lates and a single OX3:H2 isolate) that did possess stx1c. In
addition, 51 of 207 (24.6%) ovine isolates contained an stx1
subtype, and 41 (80.4%) of these belonged to serogroups (O26,
O91, O103, and O157) which have been associated with serious
human illnesses in Australia and around the world. Thus, the
ability to identify stx1c-positive STEC isolates is of clinical and
epidemiological significance, because these isolates are likely
to be less pathogenic for humans. Limited studies in Australia
(4) indicate that STEC serotypes O123:H and O128:H2, se-
rotypes that typically possess stx1c and that are commonly re-
covered from the feces of sheep, are isolated from humans with
diarrhea but without HUS (4). Similarly, investigators reported
from a study in Germany (19) that STEC isolates simulta-
neously possessing stx2d and stx1 (stx1 not subtyped) were from
asymptomatic patients (11 isolates) or patients with diarrhea
but without HUS (26 isolates) and that none of them possessed
eae. Although the stx1 subtype was not reported in that study
(19), our study shows that stx1c is typically associated with
STEC strains that possess stx2d. Furthermore, 16 of these 37
isolates (43.2%) possessed serotypes O75:H8, O91:H, and
O128:H/H2/Hnt, which are common ovine serotypes. Further
studies are required to elucidate the contribution of STEC
derived from ovine sources to milder human gastrointestinal
conditions such as diarrhea.
Of 104 bovine STEC isolates, 97 (93.3%) contained an stx1
subtype and comprised 44 serotypes; 22 of these 97 (22.7%)
belonged to serogroups O26, O111, O113, O157, and OX3,
which are associated with serious disease in humans in Aus-
tralia (16) and around the world. We and others have recently
shown that the majority of bovine STEC isolates that contain
stx2 together with either of the associated virulence factors
ehxA and eaeA possess stx2 and stx2vhb subtypes (3; our unpub-
lished data). These subtypes are commonly associated with
STEC recovered from seriously diseased patients. Collectively,
these data suggest that cattle are the reservoir of STEC strains
belonging to a diverse collection of serotypes, a subset of which
is capable of causing serious human disease.
There is mounting evidence that STEC serotypes that com-
monly inhabit the gastrointestinal tract of one ruminant spe-
cies are rarely isolated from other hosts (5–7, 14, 27, 30, 50, 58;
our unpublished data). Shiga toxin gene subtypes also appear
to associate with particular STEC serotypes and consequently
with particular ruminant hosts. For example, stx2-containing
STEC isolates recovered from ovine feces commonly possess
stx2d subtypes (46, 50, 58) whereas stx2-containing STEC iso-
lates commonly recovered from cattle feces typically possess
stx2, stx2vha, and stx2vhb subtypes (3; our published data). Sim-
ilarly, stx2e-containing STEC is typically isolated from porcine
sources and has not to our knowledge been recovered from
ovine or bovine sources (14, 26, 27, 30, 50, 58), and stx2f-
containing STEC is typically recovered from pigeons (53).
These observations are consistent with hypotheses raised by
Hoey et al. (25) which suggest that the effects of Shiga toxins
on bovine epithelial cells are likely to significantly affect the
success of colonization, dissemination, and persistence of
STEC in cattle reservoirs. Furthermore, these authors also
speculate that genetic heterogeneity among both Shiga toxin
subtypes and other associated virulence factors, particularly
serotype-dependent variation, may account for differences in
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the pathogenicity of different STEC populations for cattle and
hence the potential for distribution in humans.
In contrast to these observations, O157 STEC can be iso-
lated from different animal species including humans, cattle,
sheep, and swine (12, 14, 24, 37). Irrespective of host source,
O157 isolates have never been shown to possess stx1c or stx2d
genes and always possess either the stx1 or the stx2 and/or stx2vh
subtype, or both (3, 19, 63; our unpublished data). In the
present study we also show that some serogroups, particularly
O75:H8 (14 of 21 isolates), simultaneously possess both stx1
and stx1c subtypes. Similarly, some bovine STEC isolates have
been reported to possess as many as three different stx2 sub-
types (3). Shiga toxin genes are uniformly flanked by bacteri-
ophage-linked sequences in serologically different STEC
strains (52, 57). Collectively, these observations support the
contention that bacteriophage transmission plays a key role in
the spread of Shiga toxin genes among E. coli strains and that
serotype may influence the outcome of these interactions (30,
51, 52).
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